Last reviewed · How we verify

CKD-348 T1, CKD-348 T2, CKD-828, D097, D337,

Chong Kun Dang Pharmaceutical · Phase 1 active Small molecule

CKD-348 T1, CKD-348 T2, CKD-828, D097, D337, is a Small molecule drug developed by Chong Kun Dang Pharmaceutical. It is currently in Phase 1 development. Also known as: Sequence B.

At a glance

Generic nameCKD-348 T1, CKD-348 T2, CKD-828, D097, D337,
Also known asSequence B
SponsorChong Kun Dang Pharmaceutical
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about CKD-348 T1, CKD-348 T2, CKD-828, D097, D337,

What is CKD-348 T1, CKD-348 T2, CKD-828, D097, D337,?

CKD-348 T1, CKD-348 T2, CKD-828, D097, D337, is a Small molecule drug developed by Chong Kun Dang Pharmaceutical.

Who makes CKD-348 T1, CKD-348 T2, CKD-828, D097, D337,?

CKD-348 T1, CKD-348 T2, CKD-828, D097, D337, is developed by Chong Kun Dang Pharmaceutical (see full Chong Kun Dang Pharmaceutical pipeline at /company/chong-kun-dang-pharmaceutical).

Is CKD-348 T1, CKD-348 T2, CKD-828, D097, D337, also known as anything else?

CKD-348 T1, CKD-348 T2, CKD-828, D097, D337, is also known as Sequence B.

What development phase is CKD-348 T1, CKD-348 T2, CKD-828, D097, D337, in?

CKD-348 T1, CKD-348 T2, CKD-828, D097, D337, is in Phase 1.

Related